معرفی
Emmert Roberts is a Senior Clinical Lecturer in Addiction Psychiatry and NIHR Advanced Fellow at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience. He holds affiliations with SLaM South London and Maudsley NHS Foundation Trust as a Consultant Addiction Psychiatrist and the UK Department of Health’s Office of Health Improvement and Disparities as an Honorary Analyst. His work focuses on drug-related mortality, psychedelic therapies for addiction, opioid use disorder, and health policy.
- Education: PhD in Addiction Sciences (King’s College London, 2021), MSc Epidemiology (London School of Hygiene & Tropical Medicine, 2018), MA Medicine (2011), and MBBS from the University of Oxford (2010).
- Research Interests: Substance use epidemiology, overdose prevention, and policy interventions targeting vulnerable populations.
Key contributions include developing predictive mortality models for opioid patients and analyzing drug-related deaths in unconventional contexts (e.g., bath overdose scenarios). He has led national record-linkage studies (e.g., STADi-HuM) and co-authored UK alcohol treatment guidelines.
Recent articles explore psychedelic therapies’ potential for addiction, cannabis legalization impacts, and depot medication efficacy. His work has been published in journals like Drug and Alcohol Review and British Journal of Psychiatry.
- Awards: Multiple Early Career Research Prizes (2019, 2021), Best Paper Awards (2016-2017), and a Commonwealth Fund Harkness Fellowship (2022).
Active in policy roles, Roberts advises the UK’s National Programme on Substance Use Mortality and contributed to Dame Carol Black’s drugs review. He co-leads the BUILD2depot project exploring buprenorphine depot therapies and serves as British Journal of Psychiatry’s Associate Editor.
